Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most pellets dosed drugs. For a different perspective, see the most popular […]
Source
Which pharmaceutical companies have the most pellets dosed drugs? Read Post »
Annual Drug Patent Expirations for QLOSI Qlosi is a drug marketed by Orasis Pharms and is included in one NDA. […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Annual Drug Patent Expirations for TLANDO Tlando is a drug marketed by Verity and is included in one NDA. It […]
Source
This chart shows the companies which have received the most New Combination exclusivities in the past five years. New Combinations […]
Source
Pharmaceutical companies with the most ‘New Combination’ drugs Read Post »
XEGLYZE (abametapir) Hatchtech Patent: 8,212,038 Expiration: Jul 16, 2024 See More … For more information on how DrugPatentWatch can help […]
Source
Drug Patent Expirations for the Week of July 14, 2024 Read Post »
Annual Drug Patent Expirations for EPHEDRINE+SULFATE Ephedrine Sulfate is a drug marketed by Amneal, Dr Reddys, Endo Operations, Eugia Pharma, […]
Source
New patent for Endo Operations drug EPHEDRINE SULFATE Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most patents in Ukraine. Patents must be filed in each country (or, […]
Source
Which pharmaceutical companies have the most drug patents in Ukraine? Read Post »